Swissmedic

Summary report on authorisation – Vyvgart®

Marketing authorisation granted for Vyvgart® (efgartigimod alfa).

Low obligation Product class Pharmaceuticals Switzerland Pharmaceuticals

25.08.2026

Read the official source ↗

Published by Swissmedic. HealthSignal links to the original document; the summary above is extracted from the source text.